Home > Insider Trading > Filing (0000899243-19-018377)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741843	J. John Bolla	C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862	Chief Operations Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-06-18	2,241	$27.58	36,405	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4
The Form 4 originally filed on June 20, 2019 inadvertently reported 1,619 shares disposed on June 18, 2019. The correct amount of shares disposed on June 18, 2019, is 2,241 and is being reported in this amendment.
The number of shares beneficially owned is being updated to reflect the correct number beneficially owned, after giving effect to the transaction on June 19, 2019 previously reported on the original Form 4.